SG Americas Securities LLC Decreases Position in Mettler-Toledo International Inc. (NYSE:MTD)

SG Americas Securities LLC trimmed its stake in Mettler-Toledo International Inc. (NYSE:MTD) by 54.6% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 3,139 shares of the medical instruments supplier’s stock after selling 3,772 shares during the period. SG Americas Securities LLC’s holdings in Mettler-Toledo International were worth $3,707,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of MTD. Alliancebernstein L.P. lifted its position in Mettler-Toledo International by 9.9% in the fourth quarter. Alliancebernstein L.P. now owns 583,181 shares of the medical instruments supplier’s stock worth $713,627,000 after buying an additional 52,726 shares during the last quarter. Geode Capital Management LLC raised its stake in shares of Mettler-Toledo International by 2.0% in the fourth quarter. Geode Capital Management LLC now owns 558,471 shares of the medical instruments supplier’s stock valued at $682,340,000 after acquiring an additional 11,032 shares during the period. Price T Rowe Associates Inc. MD raised its stake in shares of Mettler-Toledo International by 6.0% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 455,739 shares of the medical instruments supplier’s stock valued at $557,680,000 after acquiring an additional 25,873 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Mettler-Toledo International by 131,246.3% in the 1st quarter. GAMMA Investing LLC now owns 386,158 shares of the medical instruments supplier’s stock worth $456,018,000 after acquiring an additional 385,864 shares during the last quarter. Finally, T. Rowe Price Investment Management Inc. boosted its stake in shares of Mettler-Toledo International by 36.1% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 363,107 shares of the medical instruments supplier’s stock worth $444,327,000 after purchasing an additional 96,300 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Mettler-Toledo International Trading Down 2.9%

MTD opened at $1,153.65 on Friday. The company has a market capitalization of $23.98 billion, a price-to-earnings ratio of 28.46, a PEG ratio of 3.30 and a beta of 1.38. Mettler-Toledo International Inc. has a 12-month low of $946.69 and a 12-month high of $1,546.93. The business’s fifty day simple moving average is $1,105.54 and its 200-day simple moving average is $1,204.23.

Mettler-Toledo International (NYSE:MTD) last issued its earnings results on Thursday, May 1st. The medical instruments supplier reported $8.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.90 by $0.29. The company had revenue of $883.74 million for the quarter, compared to analysts’ expectations of $876.61 million. Mettler-Toledo International had a net margin of 22.29% and a negative return on equity of 591.54%. The firm’s quarterly revenue was down 4.6% on a year-over-year basis. During the same period in the prior year, the business earned $8.89 EPS. On average, equities research analysts predict that Mettler-Toledo International Inc. will post 42.71 EPS for the current year.

Wall Street Analyst Weigh In

A number of analysts recently weighed in on the stock. UBS Group raised shares of Mettler-Toledo International from a “neutral” rating to a “buy” rating and reduced their price objective for the stock from $1,530.00 to $1,350.00 in a research report on Tuesday, May 20th. Citigroup upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price target on the stock in a report on Monday, April 7th. Jefferies Financial Group upgraded Mettler-Toledo International from an “underperform” rating to a “hold” rating and dropped their price objective for the company from $1,200.00 to $1,110.00 in a report on Monday, May 5th. Robert W. Baird reduced their target price on Mettler-Toledo International from $1,369.00 to $1,034.00 and set a “neutral” rating on the stock in a research note on Tuesday, April 22nd. Finally, Wall Street Zen lowered shares of Mettler-Toledo International from a “buy” rating to a “hold” rating in a research note on Monday, May 5th. Seven research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $1,302.11.

Insider Buying and Selling

In other Mettler-Toledo International news, Director Michael A. Kelly sold 1,062 shares of the stock in a transaction on Wednesday, May 28th. The stock was sold at an average price of $1,159.93, for a total transaction of $1,231,845.66. Following the sale, the director now owns 120 shares of the company’s stock, valued at approximately $139,191.60. This trade represents a 89.85% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.94% of the stock is currently owned by insiders.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.